Literature DB >> 24973608

Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography.

Jia Yu1, Chunhui Jiang2, Gezhi Xu3.   

Abstract

PURPOSE: To investigate the characteristics of subretinal exudation and consequent morphologic changes in acute central serous chorioretinopathy (CSC) using spectral-domain optical coherence tomography (OCT).
DESIGN: Prospective, observational, cross-sectional case series.
METHODS: Patients with CSC with symptom duration of fewer than 3 months underwent visual acuity measurement, fundus observation and spectral-domain OCT examinations and then were evaluated for subretinal exudation and other changes.
RESULTS: A total of 123 patients (123 eyes) were included, all showing various retinal pigment epithelium (RPE) abnormalities on OCT. OCT also showed subretinal exudation (65 eyes, 52.8%); retinal dipping (14 eyes, 11.4%); and photoreceptor layer defects (88 eyes, 71.5%). Without exception, the locations of these pathologic changes were closely related to the abnormal sites in the RPE. Those with subretinal exudation showed shorter durations of symptoms, whereas those with photoreceptor layer defects showed longer durations. In most eyes with retinal dipping, exudation connected it to RPE abnormalities. The defects of the photoreceptor layer, which involved the photoreceptor outer segment in 68 eyes, the photoreceptor inner segment in 20 eyes, and the outer nuclear layer as well, were likely to be the consequence of retinal dipping.
CONCLUSIONS: OCT findings suggested that in eyes with acute CSC subretinal exudation, which indicated fibrin leakage through the RPE defects, might cause retinal dipping, thus leading to photoreceptor layer defects, and that spectral-domain OCT could provide a better understanding of the pathologic changes in acute CSC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24973608     DOI: 10.1016/j.ajo.2014.06.015

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  [Serous retinopathy: an important adverse event in tumor treatment].

Authors:  I Lüdeke; P Terheyden; S Grisanti; M Lüke
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

2.  Clinical research of fenofibrate and spironolactone for acute central serous chorioretinopathy.

Authors:  Yong Chai; Rong-Qiang Liu; Jing-Lin Yi; Ling-Hong Ye; Jing Zou; Nan Jiang; Yi Shao
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

3.  Risk Factors and Outcomes of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy.

Authors:  Ga-In Lee; A Young Kim; Se Woong Kang; Soo Chang Cho; Kyu Hyung Park; Sang Jin Kim; Kyung Tae Kim
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

Review 4.  The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy.

Authors:  Stefano Da Pozzo; Pierluigi Iacono; Alessandro Arrigo; Maurizio Battaglia Parodi
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-29

5.  A Few-Shot Learning-Based Retinal Vessel Segmentation Method for Assisting in the Central Serous Chorioretinopathy Laser Surgery.

Authors:  Jianguo Xu; Jianxin Shen; Cheng Wan; Qin Jiang; Zhipeng Yan; Weihua Yang
Journal:  Front Med (Lausanne)       Date:  2022-03-03

6.  Correlation between Retinal Changes and Visual Function in Late-Stage Vogt-Koyanagi-Harada Disease: An Optical Coherence Tomography Study.

Authors:  Min Zhou; Chunhui Jiang; Ruiping Gu; Zhongcui Sun; Nancy Huynh; Qing Chang
Journal:  J Ophthalmol       Date:  2015-08-02       Impact factor: 1.909

7.  Clinical Characteristics of Pregnancy-Associated Central Serous Chorioretinopathy in the Chinese Population.

Authors:  Jia Yu; Lei Li; Chunhui Jiang; Qing Chang; Gezhi Xu
Journal:  J Ophthalmol       Date:  2021-12-16       Impact factor: 1.909

8.  Research on the Segmentation of Biomarker for Chronic Central Serous Chorioretinopathy Based on Multimodal Fundus Image.

Authors:  Jianguo Xu; Jianxin Shen; Qin Jiang; Cheng Wan; Zhipeng Yan; Weihua Yang
Journal:  Dis Markers       Date:  2021-09-03       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.